Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report - Report - MDSpire

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report

  • By

  • Jiaojiao Hou

  • Xiaolei Yin

  • Lili Mi

  • Xin Han

  • Ning Li

  • Fei Yin

  • June 30, 2026

  • 0 min

Share

Clinical Report: Acute Post-Renal Obstruction Due to Bladder Metastasis

Overview

This case study presents a rare instance of bladder metastasis from gastric cancer, leading to acute post-renal obstruction during immunotherapy. The patient experienced significant complications, including acute kidney injury and progressive obstructive uropathy.

Background

Bladder metastasis from gastric cancer is exceedingly rare and often misdiagnosed. Early identification of such metastases is crucial, as delayed diagnosis can lead to irreversible renal damage. Understanding the diagnostic challenges associated with immunotherapy is essential for improving patient outcomes.

Data Highlights

No numerical data or trial data were presented in the article.

Key Findings

  • Bladder metastasis from gastric cancer can present as acute post-renal obstruction.
  • Immunotherapy may complicate the clinical evaluation of new urinary symptoms.
  • Cystoscopy and targeted biopsy are critical for distinguishing between immunotherapy-related toxicity and metastatic disease.
  • The patient developed bilateral hydronephrosis and acute kidney injury despite initial response to treatment.
  • Histopathological examination confirmed poorly differentiated adenocarcinoma with signet-ring cell features.

Clinical Implications

Early cystoscopy and biopsy can facilitate timely diagnosis and management in patients with gastric cancer who develop new urinary symptoms during immunotherapy.

Conclusion

This case highlights the importance of distinguishing between immunotherapy-related adverse events and metastatic disease in patients with gastric cancer.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Frontiers in Immunology, 2026 -- Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer
  3. Frontiers in Oncology, 2026 -- Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission
  4. Gastric Cancer, 2025 -- Gallbladder swelling as an indicator of zolbetuximab-related protein-losing enteropathy in a patient with gastric cancer
  5. NCCN GUIDELINES® INSIGHTS, 2024 -- Management of Immunotherapy-Related Toxicities
  6. Frontiers in Oncology — Renal clear cell carcinoma with co-existing tumor thrombosis of renal vein and ureter: a case report and review of the literature
  7. Nivolumab plus chemotherapy as first-line treatment for advanced gastric cancer
  8. Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
  9. Immune-related ureteritis and cystitis induced by immune checkpoint inhibitors
  10. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline | ASCO Publications
  11. CE NCCN GUIDELINES® INSIGHTS Management of Immunot
  12. CK7-negative and CK20-Positive intestinal- type gastric adenocarcinoma metastasis to the bladder: A case report of an unprecedented phenotype - ScienceDirect
  13. Frontiers | A case report of primary mucinous adenocarcinoma of the bladder and literature review

Original Source(s)

Related Content